Literature DB >> 7986000

Comparison of ofloxacin and ceftriaxone for short-course treatment of enteric fever.

M D Smith1, N M Duong, N T Hoa, J Wain, H D Ha, T S Diep, N P Day, T T Hien, N J White.   

Abstract

An open, randomized comparison of ofloxacin (200 mg, every 12 h) given orally for 5 days and ceftriaxone (3 g, once daily) given intravenously for 3 days in the treatment of uncomplicated enteric fever was conducted in Ho Chi Minh City, Vietnam. Salmonella paratyphi type A was isolated from six patients. Salmonella typhi was isolated from 41 patients; 63% of these isolates were resistant to multiple antibiotics: ampicillin, chloramphenicol, sulfamethoxazole, trimethoprim, and tetracycline. Of the culture-confirmed cases, treatment with ofloxacin resulted in complete cure of all 22 patients, whereas 18 of 25 patients treated with ceftriaxone were completely cured (P < 0.01). In the ceftriaxone group, there were six acute treatment failures and one relapse. Mean +/- standard deviation fever clearance times were 81 +/- 25 h for ofloxacin and 196 +/- 87 h for ceftriaxone (P < 0.0001). Short-course treatment with oral ofloxacin (5 days) is significantly better than that with ceftriaxone (3 days) and will be of particular benefit in areas where multiresistant strains of S. typhi are encountered.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7986000      PMCID: PMC284627          DOI: 10.1128/AAC.38.8.1716

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  21 in total

Review 1.  Modern treatment of typhoid fever.

Authors:  B K Mandal
Journal:  J Infect       Date:  1991-01       Impact factor: 6.072

2.  Effects of ampicillin, ceftriaxone, chloramphenicol, pefloxacin and trimethoprim-sulphamethoxazole on Salmonella typhi within human monocyte-derived macrophages.

Authors:  H R Chang; I R Vladoianu; J C Pechère
Journal:  J Antimicrob Chemother       Date:  1990-11       Impact factor: 5.790

3.  Epidemic multiresistant enteric fever in eastern India.

Authors:  A C Anand; V K Kataria; W Singh; S K Chatterjee
Journal:  Lancet       Date:  1990-02-10       Impact factor: 79.321

4.  Ribosomal RNA gene restriction patterns provide increased sensitivity for typing Salmonella typhi strains.

Authors:  M Altwegg; F W Hickman-Brenner; J J Farmer
Journal:  J Infect Dis       Date:  1989-07       Impact factor: 5.226

5.  Open study of ciprofloxacin in enteric fever.

Authors:  P J Stanley; P J Flegg; B K Mandal; A M Geddes
Journal:  J Antimicrob Chemother       Date:  1989-05       Impact factor: 5.790

6.  Therapy of antimicrobial-resistant typhoid fever.

Authors:  T Butler; N N Linh; K Arnold; M D Adickman; D M Chau; M M Muoi
Journal:  Antimicrob Agents Chemother       Date:  1977-04       Impact factor: 5.191

7.  Treatment of typhoid fever with ceftriaxone for 5 days or chloramphenicol for 14 days: a randomized clinical trial.

Authors:  A Islam; T Butler; I Kabir; N H Alam
Journal:  Antimicrob Agents Chemother       Date:  1993-08       Impact factor: 5.191

8.  Randomized treatment of patients with typhoid fever by using ceftriaxone or chloramphenicol.

Authors:  A Islam; T Butler; S K Nath; N H Alam; K Stoeckel; H B Houser; A L Smith
Journal:  J Infect Dis       Date:  1988-10       Impact factor: 5.226

9.  Treatment of typhoid fever with ofloxacin.

Authors:  F Wang; X J Gu; M F Zhang; T Y Tai
Journal:  J Antimicrob Chemother       Date:  1989-05       Impact factor: 5.790

Review 10.  Treatment of typhoid fever and other systemic salmonelloses with cefotaxime, ceftriaxone, cefoperazone, and other newer cephalosporins.

Authors:  G B Soe; G D Overturf
Journal:  Rev Infect Dis       Date:  1987 Jul-Aug
View more
  27 in total

1.  Failure of short-course ceftriaxone chemotherapy for multidrug-resistant typhoid fever in children: a randomized controlled trial in Pakistan.

Authors:  Z A Bhutta; I A Khan; M Shadmani
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children.

Authors:  H Vinh; J Wain; T N Vo; N N Cao; T C Mai; D Bethell; T T Nguyen; S D Tu; M D Nguyen; N J White
Journal:  Antimicrob Agents Chemother       Date:  1996-04       Impact factor: 5.191

3.  Comparison of two regimens for ciprofloxacin treatment of enteric infections.

Authors:  C Agalar; S Usubütün; E Tütüncü; R Türkyilmaz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1997-11       Impact factor: 3.267

4.  A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever.

Authors:  N T Chinh; C M Parry; N T Ly; H D Ha; M X Thong; T S Diep; J Wain; N J White; J J Farrar
Journal:  Antimicrob Agents Chemother       Date:  2000-07       Impact factor: 5.191

5.  Pharmacokinetics of oral and intravenous ofloxacin in children with multidrug-resistant typhoid fever.

Authors:  D B Bethell; N P Day; N M Dung; C McMullin; H T Loan; D T Tam; L T Minh; N T Linh; N Q Dung; H Vinh; A P MacGowan; L O White; N J White
Journal:  Antimicrob Agents Chemother       Date:  1996-09       Impact factor: 5.191

6.  ENTERIC FEVER THE CHANGING SCENE.

Authors:  P C Sanchetee; S K Sharma; Ramji Rai
Journal:  Med J Armed Forces India       Date:  2017-06-26

7.  Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever.

Authors:  Christopher M Parry; Vo Anh Ho; Le Thi Phuong; Phan Van Be Bay; Mai Ngoc Lanh; Le Thanh Tung; Nguyen Thi Hong Tham; John Wain; Tran Tinh Hien; Jeremy J Farrar
Journal:  Antimicrob Agents Chemother       Date:  2006-12-04       Impact factor: 5.191

8.  Dissemination of persistent intestinal bacteria via the mesenteric lymph nodes causes typhoid relapse.

Authors:  Amanda J Griffin; Lin-Xi Li; Sabrina Voedisch; Oliver Pabst; Stephen J McSorley
Journal:  Infect Immun       Date:  2011-01-24       Impact factor: 3.441

Review 9.  Cost effectiveness of quinolones in hospitals and the community.

Authors:  P Davey
Journal:  Drugs       Date:  1999       Impact factor: 9.546

10.  Multiple antibiotic resistance (mar) locus in Salmonella enterica serovar typhimurium DT104.

Authors:  L P Randall; M J Woodward
Journal:  Appl Environ Microbiol       Date:  2001-03       Impact factor: 4.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.